GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Co-Diagnostics Inc (FRA:C97) » Definitions » Net Margin %

Co-Diagnostics (FRA:C97) Net Margin % : -1,511.42% (As of Sep. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Co-Diagnostics Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Co-Diagnostics's Net Income for the three months ended in Sep. 2024 was €-8.74 Mil. Co-Diagnostics's Revenue for the three months ended in Sep. 2024 was €0.58 Mil. Therefore, Co-Diagnostics's net margin for the quarter that ended in Sep. 2024 was -1,511.42%.

The historical rank and industry rank for Co-Diagnostics's Net Margin % or its related term are showing as below:

FRA:C97' s Net Margin % Range Over the Past 10 Years
Min: -86987.5   Med: -1700.28   Max: 56.98
Current: -580.96


FRA:C97's Net Margin % is ranked worse than
90.62% of 821 companies
in the Medical Devices & Instruments industry
Industry Median: -1.28 vs FRA:C97: -580.96

Co-Diagnostics Net Margin % Historical Data

The historical data trend for Co-Diagnostics's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Co-Diagnostics Net Margin % Chart

Co-Diagnostics Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Margin %
Get a 7-Day Free Trial Premium Member Only -2,874.23 56.98 37.45 -41.61 -518.65

Co-Diagnostics Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -243.48 -412.82 -3,676.82 -286.02 -1,511.42

Competitive Comparison of Co-Diagnostics's Net Margin %

For the Medical Devices subindustry, Co-Diagnostics's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Co-Diagnostics's Net Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Co-Diagnostics's Net Margin % distribution charts can be found below:

* The bar in red indicates where Co-Diagnostics's Net Margin % falls into.



Co-Diagnostics Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Co-Diagnostics's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin=Net Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-32.4/6.247
=-518.65 %

Co-Diagnostics's Net Margin for the quarter that ended in Sep. 2024 is calculated as

Net Margin=Net Income (Q: Sep. 2024 )/Revenue (Q: Sep. 2024 )
=-8.736/0.578
=-1,511.42 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Co-Diagnostics  (FRA:C97) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Co-Diagnostics Net Margin % Related Terms

Thank you for viewing the detailed overview of Co-Diagnostics's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Co-Diagnostics Business Description

Traded in Other Exchanges
Address
2401 South Foothill Drive, Salt Lake City, UT, USA, 84109
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.

Co-Diagnostics Headlines

No Headlines